Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Somatuline Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Somatuline Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 60 mg
      • 1.3.3 90 mg
      • 1.3.4 120 mg
    • 1.4 Market Segment by Application
      • 1.4.1 Global Somatuline Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Pharmacy
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Somatuline Market Size
      • 2.1.1 Global Somatuline Revenue 2014-2025
      • 2.1.2 Global Somatuline Sales 2014-2025
    • 2.2 Somatuline Growth Rate by Regions
      • 2.2.1 Global Somatuline Sales by Regions 2014-2019
      • 2.2.2 Global Somatuline Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Somatuline Sales by Manufacturers
      • 3.1.1 Somatuline Sales by Manufacturers 2014-2019
      • 3.1.2 Somatuline Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Somatuline Revenue by Manufacturers (2014-2019)
      • 3.2.2 Somatuline Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Somatuline Market Concentration Ratio (CR5 and HHI)
    • 3.3 Somatuline Price by Manufacturers
    • 3.4 Key Manufacturers Somatuline Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Somatuline Market
    • 3.6 Key Manufacturers Somatuline Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 60 mg Sales and Revenue (2014-2019)
      • 4.1.2 90 mg Sales and Revenue (2014-2019)
      • 4.1.3 120 mg Sales and Revenue (2014-2019)
    • 4.2 Global Somatuline Sales Market Share by Type
    • 4.3 Global Somatuline Revenue Market Share by Type
    • 4.4 Somatuline Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Somatuline Sales by Application

    6 United States

    • 6.1 United States Somatuline Breakdown Data by Company
    • 6.2 United States Somatuline Breakdown Data by Type
    • 6.3 United States Somatuline Breakdown Data by Application

    7 European Union

    • 7.1 European Union Somatuline Breakdown Data by Company
    • 7.2 European Union Somatuline Breakdown Data by Type
    • 7.3 European Union Somatuline Breakdown Data by Application

    8 China

    • 8.1 China Somatuline Breakdown Data by Company
    • 8.2 China Somatuline Breakdown Data by Type
    • 8.3 China Somatuline Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Somatuline Breakdown Data by Company
    • 9.2 Rest of World Somatuline Breakdown Data by Type
    • 9.3 Rest of World Somatuline Breakdown Data by Application
    • 9.4 Rest of World Somatuline Breakdown Data by Countries
      • 9.4.1 Rest of World Somatuline Sales by Countries
      • 9.4.2 Rest of World Somatuline Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 IPSEN
      • 10.1.1 IPSEN Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Somatuline
      • 10.1.4 Somatuline Product Introduction
      • 10.1.5 IPSEN Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Somatuline Sales Channels
      • 11.2.2 Somatuline Distributors
    • 11.3 Somatuline Customers

    12 Market Forecast

    • 12.1 Global Somatuline Sales and Revenue Forecast 2019-2025
    • 12.2 Global Somatuline Sales Forecast by Type
    • 12.3 Global Somatuline Sales Forecast by Application
    • 12.4 Somatuline Forecast by Regions
      • 12.4.1 Global Somatuline Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Somatuline Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
      In 2019, the market size of Somatuline is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Somatuline.

      This report studies the global market size of Somatuline, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Somatuline sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      IPSEN
      ...

      Market Segment by Product Type
      60 mg
      90 mg
      120 mg

      Market Segment by Application
      Hospital
      Pharmacy

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Somatuline status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Somatuline manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Somatuline are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now